Indeed, specific genetic alterations including those of PTEN in cancer cells may affect the immune composition of the TME (see Figure 3 for a schematic representation), and such infiltrating immune cells may in turn act to inhibit or sustain cancer cells proliferation [99]. This evidence concerns the gene PTEN and cancer.